155 results on '"Li, Pansong"'
Search Results
2. Immune characteristics associated with lymph node metastasis in early-stage NSCLC
3. Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy
4. The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial
5. Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma
6. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
7. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
8. Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma
9. Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
10. Immune characteristics associated with lymph node metastasis in early-stage NSCLC
11. Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis
12. Abstract 5578: Analytical validation of an NGS-based, personalized and tumor-informed liquid biopsy assay for detecting minimal residual disease (MRD) with high sensitivity and specificity
13. Table S13 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
14. Figure S5 from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
15. Supplementary legend from Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
16. Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing
17. Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.
18. CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types
19. bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti‐angiogenic agent apatinib combination therapy
20. Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
21. Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
22. Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumors
23. Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma
24. Identification of Pyroptosis-related Gene Prognostic Signature in Patients with Hepatocellular Carcinoma
25. Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
26. Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma
27. T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer
28. Overexpression of TaHSF3 in Transgenic Arabidopsis Enhances Tolerance to Extreme Temperatures
29. Abstract 2492: Association of TP53 and LRP1B co-mutation status with response to immunotherapy in lung squamous cell carcinoma
30. Abstract 1412: Whole exome sequencing reveals PI3K-ATK pathway alterations are frequent in relapsed small cell-lung cancer after chemoradiation
31. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single‐base resolution methylome and hydroxymethylome
32. CDKN2A or CDKN2B homozygous deletion with high-immune infiltration as a favorable prognostic factor for lung adenocarcinoma.
33. PI3K-AKT pathway alterations are revealed as a potential mechanism of chemoradiation resistance in small cell lung cancer by whole-exome sequencing.
34. Immune heterogeneity in adenocarcinoma and squamous cell carcinoma components of lung adenosquamous carcinoma.
35. Spatial analysis of the T-cell repertoire in non-small cell lung cancer reveals a clonality gradient from the tumor to the distal lung.
36. Additional file 11 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
37. Additional file 8 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
38. Additional file 2 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
39. Additional file 9 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
40. Additional file 3 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
41. Additional file 7 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
42. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome
43. Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
44. Tumor-derived mutations in postoperative plasma of colorectal cancer with microsatellite instability
45. Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma
46. Abstract 410: Interaction between CAFs and CD8+ T in non-small cell lung cancer (NSCLC) affects prognosis and efficacy of immunotherapy
47. Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma
48. Intratumoral heterogeneity and tumor evolution of small cell lung cancer through multi-regional sequencing.
49. Interaction between CAF and CD8+ T cells in non-small cell lung cancer affects prognosis and efficacy of immunotherapy.
50. Genomic origin and immune-related status of pulmonary sarcomatoid carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.